REQUEST A DEMO
Total
USD $0.00
Search more companies

Dynex Laboratories, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores
Full name: Dynex Laboratories, S.R.O. Profile Updated: December 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dynex Laboratories, S.R.O. is an enterprise based in Czech Republic. Its main office is in Prague. The company operates in the Pharmacies and Drug Stores sector. It was first established on March 25, 2002. 25 - 49 (2024) employees currently work for Dynex Laboratories, S.R.O.. In its most recent financial highlights, the company reported a net sales revenue drop of 50.39% in 2023. Its’ total assets recorded a negative growth of 31.73%. Dynex Laboratories, S.R.O.’s net profit margin decreased by 20.16% in 2023.

Headquarters
Vodickova 791/41
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Dynex Laboratories, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dynex Laboratories, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Dynex Laboratories, S.R.O. report to view the information.
Registered Capital:
Purchase the Dynex Laboratories, S.R.O. report to view the information.
Incorporation Date:
March 25, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dynex Laboratories, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-50.39%
Total operating revenue
-49.57%
Operating profit (EBIT)
-85.22%
EBITDA
-78.38%
Net Profit (Loss) for the Period
-75.88%
Total assets
-31.73%
Total equity
-12.35%
Operating Profit Margin (ROS)
-34.68%
Net Profit Margin
-20.16%
Return on Equity (ROE)
-13.12%
Quick Ratio
112.15%
Cash Ratio
61.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?